|
IQVIA™ Real-World Insights Bibliography
| Estimating the burden of influenza-related and associated hospitalizations and deaths in France: An eight-season data study, 2010-2018 |
| Author(s): Magali Lemaitre 1, Fayssoil Fouad 1, Fabrice Carrat 2 3, Pascal Crépey 4, Jacques Gaillat 5, Gaëtan Gavazzi 6, Odile Launay 7 8, Anne Mosnier 9, Marie-Cécile Levant 10, Mathieu Uhart 10 |
| Affiliations(s): 1 IQVIA, Courbevoie, France.
2 Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (Inserm), Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
3 Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Unité de Santé Publique, Paris, France.
4 Université de Rennes, EHESP, REPERES-EA 7449, Rennes, France.
5 Centre Hospitalier Annecy-Genevois, Metz-Tessy, France.
6 CHU Grenoble Alpes, Clinique Universitaire de Gériatrie, Pavillon Elisée-Chatin, and GREPI EA 7408, Université Grenoble Alpes, Grenoble, France.
7 Faculté de Médecine Paris Descartes, Université de Paris, Paris, France.
8 Inserm, CIC 1417, F-CRIN I-REIVAC, Assistance Publique-Hôpitaux de Paris, CIC Cochin-Pasteur, Paris, France.
9 Open Rome & Réseau des GROG, Paris, France.
10 Sanofi Pasteur, Lyon, France. |
Publication(s): Influenza Other Respir Viruses
. 2022 Jan 10. doi: 10.1111/irv.12962.
|
| Document Type(s): Abstract, |
| Countries: France, |
| Click here for the abstract |
C:
Y: |
Infectious disease, Respiratory disease,
2022 |
|
L:
A: |
English
Methodology, Population Based Study, |
|
 |
| |
| |
| Treatment Patterns, Socioeconomic Status and Clinical Burden in Mild COPD: A Swedish Real-World, Retrospective Cohort Study, the ARCTIC Study |
| Author(s): Kjell Larsson,1 Karin Lisspers,2 Björn Ställberg,2 Gunnar Johansson,2 Florian S Gutzwiller,3 Karen Mezzi,3 Bine Kjoeller Bjerregaard,4 Leif Jorgensen,4 Hyewon Koo,5 Christer Janson6 |
| Affiliations(s): 1Integrative Toxicology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 2Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden; 3Novartis Pharma AG, Basel, Switzerland; 4IQVIA Solutions, Copenhagen, Denmark; 5IQVIA Solutions, Solna, Sweden; 6Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden |
Publication(s): International Journal of Chronic Obstructive Pulmonary Disease 2022:17 1409?1421 https://doi.org/10.2147/COPD.S364932
PMID 35761954
|
| Document Type(s): Article, |
| Countries: Sweden, |
| Click here for the abstract |
C:
Y: |
Respiratory disease,
2022 |
|
L:
A: |
English
Clinical setting: Primary care, Epidemiological study, Population Based Study, Real World Data, Retrospective cohort analysis, |
|
|
| |
| |
| Investigating the secondary care system burden of CRSwNP in sinus surgery patients with clinically relevant comorbidities using the HES database |
| Author(s): C. Hopkins - S. Conlon - S. Chavda - R. Hudson - R. Rout |
| Affiliations(s): Guy's and St. Thomas' Hospital, Kings college, London, UK.
Sanofi Genzyme UK, Reading, UK.
IQVIA, London, UK. |
Publication(s): Rhinology 60-4: 252-260, 2022
|
| Document Type(s): Article, |
| Countries: England, |
| Click here for the abstract |
C:
Y: |
Respiratory disease, Surgery,
2022 |
|
L:
A: |
English
Budget impact, Burden of illness, Cost analysis, Retrospective database analysis, |
|
|
| |
| |
| Predicting Hospitalization Due to COPD Exacerbations in Swedish Primary Care Patients Using Machine Learning ? Based on the ARCTIC Study |
| Author(s): Björn Ställberg 1, Karin Lisspers 1, Kjell Larsson 2, Christer Janson 3, Mario Müller 4, Mateusz Łuczko 5, Bine Kjøller Bjerregaard 6, Gerald Bacher 7, Björn Holzhauer 7, Pankaj Goyal 7, Gunnar Johansson 1 |
| Affiliations(s): 1Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden.
2Integrative Toxicology, Karolinska Institutet, Stockholm, Sweden.
3Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
4Department of Data Science and Advanced Analytics, IQVIA, Frankfurt Am Main, Germany.
5Department of Data Science and Advanced Analytics, IQVIA, Warsaw, Poland.
6Department of Real World Evidence Solutions, IQVIA, Copenhagen, Denmark.
7Department of Clinical Development and Analytics, Novartis Pharma AG, Basel, Switzerland. |
Publication(s): Journal: Int J Chron Obstruct Pulmon Dis. 2021 Mar 16;16:677-688. doi: 10.2147/COPD.S293099. eCollection 2021.
Conference: IPCRG, Dublin, Ireland, Weekly series of Clinical Practice Webinars - Various Saturdays from 16th May to 27th June 2020
PMID: 33758504 PMCID: PMC7981164 DOI: 10.2147/COPD.S293099
|
| Document Type(s): Article, |
| Countries: Sweden, |
| Click here for the abstract |
C:
Y: |
Respiratory disease,
2021 |
|
L:
A: |
English
Epidemiological study, Population Based Study, |
|
|
| |
| |
| SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason
|
| Author(s): Christina D. Mack; John DiFiori; Caroline G. Tai; Kristin Y. Shiue; Yonatan H. Grad; Deverick J. Anderson; David D. Ho; Leroy Sims;
Christopher LeMay; Jimmie Mancell; Lisa L Maragakis |
| Affiliations(s): 1 IQVIA, Durham, NC, USA (Mack, Tai, Shiue)
2 Hospital for Special Surgery (DiFiori)
3 National Basketball Association, New York, New York (DiFiori, Sims, LeMay)
4 Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Grad)
5 Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina (Anderson)
6 Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, New York (Ho)
7 Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee(Mancell)
8 Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland (Maragakis) |
Publication(s): JAMA Intern Med. Published online April 22, 2021. doi:10.1001/jamainternmed.2021.2114
|
| Document Type(s): Article, |
| Countries: USA, |
| Click here for the abstract |
C:
Y: |
Respiratory disease,
2021 |
|
L:
A: |
English
Epidemiological study, Observational study, Retrospective database analysis, |
|
|
| |
| |
| Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China |
| Author(s): Ahmed Salem # 1, Heng Zhong # 2, Mafalda Ramos 1, Mark Lamotte 1, Hao Hu 3
|
| Affiliations(s): 1Real World Evidence, IQVIA, Zaventem, Belgium.
2R&D China, AstraZeneca R&D, Shanghai, China.
3Institute of Chinese Medical Sciences, University of Macau, Macau, China haohu@um.edu.mo.
#Contributed equally. |
Publication(s): BMJ Open 2021;11:e043664. doi:10.1136/bmjopen-2020-043664
e043664. doi:10.1136/bmjopen-2020-043664
PMID: 33910947 PMCID: PMC8094343 DOI: 10.1136/bmjopen-2020-043664
|
| Document Type(s): Article, |
| Countries: Belgium, China, |
| Click here for the abstract |
C:
Y: |
Health economics, Respiratory disease,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, Cost effectiveness, |
|
|
| |
| |
| Developing a short-term prediction model for asthma exacerbations from Swedish primary care patients? data using machine learning - based on the ARCTIC study Respiratory Medicine |
| Author(s): Karin Lisspers a,*, Bj¨orn St¨allberg a, Kjell Larsson b, Christer Janson c, Mario Müller d,
Mateusz Łuczko e, Bine Kjøller Bjerregaard f, Gerald Bacher g, Bj¨orn Holzhauer g, Pankaj Goyal g,
Gunnar Johansson a |
| Affiliations(s): a Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden
b Integrative Toxicology, Karolinska Institutet, Stockholm, Sweden
c Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden
d IQVIA, Frankfurt am Main, Germany
e IQVIA, Warsaw, Poland
f IQVIA, Copenhagen, Denmark
g Novartis Pharma AG, Basel, Switzerland |
| Publication(s): |
| Document Type(s): |
| Countries: Sweden, |
| Click here for the abstract |
C:
Y: |
Respiratory disease,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, clinical setting: Secondary care, Predictive analytics, |
|
|
| |
| |
| Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy
|
| Author(s): Mennini FS, Gori M, Vlachaki I, Fiorentino F, La Malfa P, Urbinati D, Andreoni M
|
| Affiliations(s): Mennini FS: EEHTA CEIS, Faculty of Economics, University of Rome "Tor Vergata", Rome, Italy; Fiorentino F, La Malfa P, Urbinati D: IQVIA Solutions Italy Srl, RWS
|
Publication(s): Health Econ Rev. 2021 Oct 30;11(1):42. doi: 10.1186/s13561-021-00341-z. PMID: 34716794; PMCID: PMC8557067.
|
| Document Type(s): Article, |
| Countries: Italy, |
| Click here for the abstract |
C:
Y: |
Respiratory disease,
2021 |
|
L:
A: |
English
clinical setting: Secondary care, Cost effectiveness, |
|
|
| |
| |
| The Burden of Short-Acting ? 2-Agonist Use in Asthma: Is There an Italian Case? An Update from SABINA Program
|
| Author(s): Di Marco F, D'Amato M, Lombardo FP, Micheletto C, Heiman F, Pegoraro V, Boarino S, Manna F, Mastromauro F, Spennato S, Papi A
|
| Affiliations(s): Di Marco F: Department of Health Sciences, University of Milan, Respiratory Unit, ASST Papa Giovanni XXIII, Bergamo, Italy. Pegoraro V, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy,
|
Publication(s): Adv Ther. 2021 May 27. doi: 10.1007/s12325-021-01772-0
|
| Document Type(s): Article, |
| Countries: Italy, |
| Click here for the abstract |
C:
Y: |
Respiratory disease,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis, |
|
|
| |
| |
| Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018 |
| Author(s): C Demont 1, N Petrica 2, I Bardoulat 2, S Duret 2, L Watier 3, A Chosidow 4, M Lorrot 4, A Kieffer 5, M Lemaitre 2 |
| Affiliations(s): 1Sanofi Pasteur, 14 Espace Henry Vallée, 69007, Lyon, France. Clarisse.Demont@sanofi.com.
2IQVIA, 92400, Courbevoie, France.
3Université Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France.
4Department of Pediatrics, Armand Trousseau Hospital (AP-HP), 75012, Paris, France.
5Sanofi Pasteur, 14 Espace Henry Vallée, 69007, Lyon, France. |
Publication(s): BMC Infect Dis
. 2021 Aug 2;21(1):730. doi: 10.1186/s12879-021-06399-8.
|
| Document Type(s): Abstract, |
| Countries: France, |
| Click here for the abstract |
C:
Y: |
Infectious disease, Respiratory disease,
2021 |
|
L:
A: |
English
Observational study, Population Based Study, |
|
|
| |
| |
 1 of 27 
|
|
